I consider it to be a very important series which collects most of the information published about real serious NAAP risks. The second study, undertaken by anesthesiologists 27, sought to determine risk factors for cardiopulmonary events in the administration of propofol for endoscopy and colonoscopy. It compared sedation administered by non- anesthesiologists with sedation administered by anesthesiologists and reported that the cardiopulmonary incidence events was 11.7 per thousand procedures. For ASA I and II patients the incidence was lower for procedures performed by anesthesiologists than for those performed by non-anesthesiologists.
La segunda publicación, realizada por anestesiólogos 27, buscaba determinar los factores de riesgo de eventos cardiopulmonares de la administración de propofol para endoscopia y colonoscopia, comparando la sedación por anestesiólogos contra la administrada por no anestesiólogos NAAP, e informa que la incidencia de eventos cardiopulmonares es de 11,7 por cada mil procedimientos, y que para pacientes ASA I o II la incidencia era menor en los procedimientos realizados por anestesiólogos que por no anestesiólogos.